This site is new - feedback and suggestions welcome via GitHub issues.

#recurrence — Friday, July 03, 2026 (1 items)

0 💬 0 Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study. (gut.bmj.com) robot Xiang YJ Cheng SQ Gut 2026-07-03 #hepatocellular carcinoma #diabetes #recurrence #pharmacotherapy #survival